Literature DB >> 26113585

Neuroborreliosis: the Guillain-Barré mimicker.

Niharika Tyagi1, Tim Maheswaran1, Sunil Wimalaratna2.   

Abstract

A 34-year-old woman presented to the medical admissions unit with progressive ascending weakness of her limbs and areflexia. Diagnosis of Guillain-Barré syndrome was suspected and she was started on intravenous immunoglobulins. Owing to a poor initial response, further exploratory history revealed travel to the New Forest and a possible tick bite; subsequent investigations confirmed positive serology for antibodies against Borrelia. The patient's weakness improved with intravenous ceftriaxone for neuroborreliosis, a manifestation of Lyme disease. With inpatient neurorehabilitation, she made good recovery and was able to mobilise with a stick from being completely bed bound 6 weeks after completion of her antibiotics. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26113585      PMCID: PMC4488652          DOI: 10.1136/bcr-2014-209080

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable.

Authors:  A Prasad; D Sankar
Journal:  Postgrad Med J       Date:  1999-11       Impact factor: 2.401

Review 2.  Guillain-Barré syndrome.

Authors:  Jane Pritchard
Journal:  Clin Med (Lond)       Date:  2010-08       Impact factor: 2.659

3.  Demyelinating neuropathy accompanying Lyme disease.

Authors:  A B Sterman; S Nelson; P Barclay
Journal:  Neurology       Date:  1982-11       Impact factor: 9.910

Review 4.  Lyme disease in the United Kingdom.

Authors:  Simon W Dubrey; Ajay Bhatia; Sarah Woodham; Wojtek Rakowicz
Journal:  Postgrad Med J       Date:  2013-11-06       Impact factor: 2.401

5.  Demonstration of Borrelia burgdorferi infection in a child with Guillain-Barré syndrome.

Authors:  G Horneff; H I Huppertz; K Müller; T Voit; H Karch
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

6.  Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis.

Authors:  H W Pfister; V Preac-Mursic; B Wilske; E Schielke; F Sörgel; K M Einhäupl
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

7.  Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E D Shapiro; E Logigian; A L Belman; L Dotevall; G P Wormser; L Krupp; G Gronseth; C T Bever
Journal:  Neurology       Date:  2007-05-23       Impact factor: 9.910

8.  Neuroborreliosis in the South West of England.

Authors:  J K Lovett; P H Evans; S O'Connell; N J Gutowski
Journal:  Epidemiol Infect       Date:  2008-03-06       Impact factor: 2.451

  8 in total
  2 in total

1.  Atypical Case of Lyme Neuroborreliosis With Hyponatremia.

Authors:  Dhara Rana; Mujtaba Chohan; Nagwa Hafez
Journal:  Cureus       Date:  2022-04-23

2.  Confirmed cases of Neuroborreliosis with involvement of peripheral nervous system: Description of a cohort.

Authors:  Anne-Laure Kaminsky; Thierry Maisonobe; Timothée Lenglet; Dimitri Psimaras; Rabab Debs; Karine Viala
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.